In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.
AZoLifeSciences on MSN
Artificial intelligence enables stable intrabody design in cells
A new artificial intelligence-driven pipeline developed in a collaborative research combines protein structure prediction, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results